Development
Healwell AI Inc.
AIDX.TO
TSX
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | 2.05M | 2.36M | 2.42M | 10.17M | 2.37M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 2.05M | 2.36M | 2.42M | 10.17M | 2.37M |
Cost of Revenue | 1.61M | 1.75M | 1.71M | 6.65M | 1.65M |
Gross Profit | 441.40K | 614.90K | 704.60K | 3.51M | 710.50K |
SG&A Expenses | 3.83M | 3.02M | 2.38M | 6.30M | 2.93M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 6.12M | 5.29M | 5.47M | 14.62M | 5.99M |
Operating Income | -4.06M | -2.93M | -3.05M | -4.45M | -3.62M |
Income Before Tax | -5.79M | -8.89M | -5.49M | -2.72M | -4.07M |
Income Tax Expenses | -162.50K | -519.60K | -149.30K | -194.50K | 2.69M |
Earnings from Continuing Operations | -5.63M | -8.37M | -5.35M | -2.52M | -6.76M |
Earnings from Discontinued Operations | -141.70K | 1.07M | -163.40K | -- | -214.60K |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -35.80K | 6.00K | 15.50K | -92.10K | 49.10K |
Net Income | -5.81M | -7.30M | -5.49M | -2.62M | -6.93M |
EBIT | -4.06M | -2.93M | -3.05M | -4.45M | -3.62M |
EBITDA | -3.85M | -2.69M | -2.81M | -4.25M | -2.95M |
EPS Basic | -0.11 | -0.14 | -0.11 | -0.05 | -0.14 |
Normalized Basic EPS | -0.05 | -0.04 | -0.04 | -0.06 | -0.05 |
EPS Diluted | -0.11 | -0.14 | -0.11 | -0.05 | -0.14 |
Normalized Diluted EPS | -0.05 | -0.04 | -0.04 | -0.06 | -0.05 |
Average Basic Shares Outstanding | 53.87M | 53.87M | 51.93M | 50.08M | 50.08M |
Average Diluted Shares Outstanding | 53.87M | 53.87M | 51.93M | 50.08M | 50.08M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -3.27% | -- |